Dublin, April 08, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "DNA Sequencing - Technologies, Markets and Companies" to their offering.
This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer.
Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.
Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2015 is described with estimates for 2020 and 2025. Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.
The report includes profiles of 135 companies involved in sequencing and their 143 collaborations. The report text is supplementd by 40 tables, 21 figures and 500 selected references to the literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. DNA Sequencing Technologies
3. Role of Bioinformatics in Sequencing
4. Comparative Analysis of Sequencing Technologies
5. Sequencing for Research
6. Applications of Sequencing in Healthcare
7. Applications of Sequencing in Oncology
8. Sequencing in Genetic Disorders
9. Sequencing in Neurological and Psychiatric Disorders
10. Applications of sequencings in infections
11. Role of Sequencing in Personalized Medicine
12. Current Status and Future Prospects
13. Markets for Sequencers
14. Companies Involved in Sequencing
15. References
For more information visit http://www.researchandmarkets.com/research/cgccp8/dna_sequencing
Source: Jain PharmaBiotech
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Genomics, Genomics


NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest
CATL Stock Hits Record High After Q1 2025 Earnings Surge
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 



